ALNY·02043Q107·US·equity·Healthcare - Biotechnology-13D/G
ALNY (ALNYLAM PHARMACEUTICALS INC) is held by 285 institutional investors as of Q1 2026. Largest holders: FMR LLC ($4.8B), Capital World Investors ($3.6B), BlackRock, Inc. ($3.5B). Net institutional sentiment: Mixed.
See how ALNY's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer